🏅 FDA Orphan Designation
Cuvrior
trientine tetrahydrochloride
Manufacturer: Orphalan
Indicated for:
FDA-Approved Indications (1)
Rare atrial defect and interatrial communicationOrphan Designation
Treatment of adult patients with stable Wilson�s disease who are de-coppered and tolerant to penicillamine
Indications & Usage
1 INDICATIONS AND USAGE CUVRIOR is indicated for the treatment of adult patients with stable Wilson's disease who are de-coppered and tolerant to penicillamine. CUVRIOR is a copper chelator indicated for the treatment of adult patients with stable Wilson's disease who are de-coppered and tolerant to penicillamine. ( 1 )
💙 Support Programs
View all →Cuvrior
Orphalan
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.